![](/img/cover-not-exists.png)
An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial
Patricia Massicotte, Jim A Julian, Michael Gent, Karen Shields, Velma Marzinotto, Barbara Szechtman, Anthony K Chan, Maureen AndrewVolume:
109
Year:
2003
Language:
english
DOI:
10.1016/s0049-3848(03)00099-9
File:
PDF, 212 KB
english, 2003